Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Kraig Biocraft Laboratories (KBLB) Invested Capital (2016 - 2022)

Kraig Biocraft Laboratories (KBLB) has disclosed Invested Capital for 11 consecutive years, with -$3.7 million as the latest value for Q3 2022.

  • Quarterly Invested Capital rose 36.31% to -$3.7 million in Q3 2022 from the year-ago period, while the trailing twelve-month figure was -$3.7 million through Sep 2022, up 36.31% year-over-year, with the annual reading at -$5.2 million for FY2021, N/A changed from the prior year.
  • Invested Capital hit -$3.7 million in Q3 2022 for Kraig Biocraft Laboratories, roughly flat from -$3.7 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of -$1.1 million in Q4 2018 to a low of -$6.8 million in Q1 2021.
  • Historically, Invested Capital has averaged -$4.2 million across 4 years, with a median of -$4.0 million in 2018.
  • Biggest YoY gain for Invested Capital was 67.14% in 2018; the steepest drop was 34.53% in 2018.
  • Year by year, Invested Capital stood at -$1.1 million in 2018, then plummeted by 310.15% to -$4.6 million in 2019, then decreased by 15.07% to -$5.2 million in 2021, then rose by 28.94% to -$3.7 million in 2022.
  • Business Quant data shows Invested Capital for KBLB at -$3.7 million in Q3 2022, -$3.7 million in Q2 2022, and -$4.0 million in Q1 2022.